Interleukin-10 as a Marker of Disease Progression in Dengue Hemorrhagic Fever.

Objective: To evaluate the plasma interleukin-10 (IL-10) levels in patients suffering from dengue hemorrhagic fever between 4 to 7 days of onset of disease and 24 hours after the first sample, to find out the association of plasma IL-10 levels with the outcome.

Study Design: Analytical study.

Place And Duration Of Study: All major hospitals of Lahore, Pakistan, from August to November 2012.